Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Predictors of anticoagulation in hospice patients with lung cancer
Holly M. Holmes
, Kevin T. Bain
, Ali Zalpour
, Ruili Luo
, Eduardo Bruera
,
James S. Goodwin
Internal Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
14
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Predictors of anticoagulation in hospice patients with lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anticoagulation
100%
Lung Cancer
100%
Hospice
100%
Hospice Patients
100%
Anticoagulants
80%
Low Molecular Weight Heparin
60%
Warfarin
60%
Medication Information
40%
Anticoagulant Use
40%
Geographic Region
20%
Long-stay
20%
Comorbid Conditions
20%
Logistic Regression Model
20%
Patients with Cancer
20%
Thromboembolism
20%
Nursing and Health Professions
Lung Cancer
100%
Anticoagulation
100%
Anticoagulant Agent
100%
Warfarin
50%
Low Molecular Weight Heparin
50%
Practice Guideline
16%
Logistic Regression Analysis
16%
Thromboembolism
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Anticoagulant Agent
100%
Low Molecular Weight Heparin
50%
Warfarin
50%
Malignant Neoplasm
16%
Retrospective Study
16%
Thromboembolism
16%
Diseases
16%